Literature DB >> 15509827

Doxorubicin-induced myocardial injury.

George Fujisaki, Chiho Inokuchi, Naoko Murashige.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15509827     DOI： 10.1056/NEJM200410283511819

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Hbo1 is a cyclin E/CDK2 substrate that enriches breast cancer stem-like cells.

Authors:  Mylinh T Duong; Said Akli; Sira Macalou; Anna Biernacka; Bisrat G Debeb; Min Yi; Kelly K Hunt; Khandan Keyomarsi
Journal:  Cancer Res       Date:  2013-08-16       Impact factor: 12.701

2.  Cardiomyocyte Stim1 Deficiency Exacerbates Doxorubicin Cardiotoxicity by Magnification of Endoplasmic Reticulum Stress.

Authors:  Jiang Zhu; Xia Zhang; Hong Xie; Yuye Wang; Xiaoxiao Zhang; Zhaoheng Lin
Journal:  J Inflamm Res       Date:  2021-08-14

3.  Costunolide enhances doxorubicin-induced apoptosis in prostate cancer cells via activated mitogen-activated protein kinases and generation of reactive oxygen species.

Authors:  Jiasheng Chen; Binshen Chen; Zhihui Zou; Wei Li; Yiming Zhang; Jinlin Xie; Chunxiao Liu
Journal:  Oncotarget       Date:  2017-11-21

4.  Targeting Extracellular Heat Shock Protein 70 Ameliorates Doxorubicin-Induced Heart Failure Through Resolution of Toll-Like Receptor 2-Mediated Myocardial Inflammation.

Authors:  Peng Liu; Hua-Yan Bao; Cai-Cai Jin; Ji-Chao Zhou; Fang Hua; Ke Li; Xiao-Xi Lv; Bing Cui; Zhuo-Wei Hu; Xiao-Wei Zhang
Journal:  J Am Heart Assoc       Date:  2019-10-02       Impact factor: 5.501
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.